1. СOVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). 2020.
2. Guan W.J., Ni Z.Y., Hu Y., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382 (18): 1708–20. DOI: https://doi.org/10.1056/NEJMoa2002032
3. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323 (13): 1239–42. DOI: https://doi. org/10.1001/jama.2020.2648
4. Gagliardi I., Patella G., Michael A., et al. COVID-19 and the kidney: from epidemiology to clinical practice. J Clin Med. 2020; 9 (8): 2506. DOI: https://doi.org/10.3390/jcm9082506
5. Cheng Y., Luo R., Wang K., et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020; 97 (5): 829–38. DOI: https://doi.org/10.1016/j.kint.2020.03.005
6. Wang L., Li X., Chen H., et al. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. Am J Nephrol. 2020; 51 (5): 343–8. DOI: https://doi. org/10.1159/000507471
7. Zhang J., Litvinova M., Wang W., et al. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. Lancet Infect Dis. 2020; 20 (7): 793–802. DOI: https://doi.org/10.1016/S1473-3099(20)30230-9
8. Ronco C., Reis T., Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020; 8 (7): 738–42. DOI: https://doi.org/10.1016/S2213-2600(20)30229-0
9. Meijers B., Messa P., Ronco C. Safeguarding the maintenance hemodialysis patient population during the coronavirus disease 19 pandemic. Blood Purif. 2020; 49 (3): 259–64. DOI: https://doi.org/10.1159/000507537
10. Basile C., Combe C., Pizzarelli F., et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysiscentres. Nephrol Dial Transplant. 2020; 35 (5): 737–41. DOI: https://doi.org/10.1093/ndt/gfaa069
11. Allen M.,Bhanji A., Willemsen J., et al. A simulation modelling toolkit for organising outpatient dialysis services during the COVID-19 pandemic. PLoS One. 2020; 15 (8): e0237628. DOI: https://doi.org/10.1371/ journal.pone.0237628
12. COVID-19 Registro ERA-EDTA. URL: https://www.era-edta.org/en/registry/covid-19 (date of access July 14, 2020)
13. Alberici F., Delbarba E., Manenti C., et al. Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep. 2020; 5 (5): 580–5. DOI: https://doi.org/10.1016/j.ekir.2020.04.001
14. Scarpioni R., Manini A., Valsania T., et al. Covid-19 and its impact on nephropathic patients: the experience at Ospedale «Guglielmo da Saliceto» in Piacenza. G Ital Nefrol. 2020; 37 (2): 1–5. DOI: https://doi.org/10.1101/2020.02.24.20027201
15. Xiong F., Tang H., Liu L., et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China. J Am Soc Nephrol. 2020; 31 (7): 1387–97. DOI: https://doi.org/10.1681/ ASN.2020030354
16. Rombola G., Brunini F. COVID-19 and dialysis: why we should be worried. J Nephrol. 2020; 33 (3): 401–3. DOI: https://doi.org/10.1007/ s40620-020-00737-w
17. Cho J.H., Kang S.H., Park H.C., et al. Hemodialysis with cohort isolation to prevent secondary transmission during a COVID-19 outbreak in Korea. J Am Soc Nephrol. 2020; 31 (7): 1398–408. DOI: https://doi. org/10.1681/ASN.2020040461
18. Chen C.Y., Shao S.C., Chen Y.T., et al. Incidence and clinical impacts of COVID-19 infection in patients with hemodialysis: systematic review and meta-analysis of 396,062 hemodialysis patients. Healthcare (Basel). 2021; 9 (1): 47. DOI: https://doi.org/10.3390/healthcare9010047
19. International Society of Nephrology. URL: https://www.theisn.org/covid19/recommendations
20. COVID-19 Registro ERA-EDTA. URL: https://www.era-edta.org/en/registry/covid-19 (date of access August 3, 2020)
21. Khatri M., Islam S., Dutka P., et al. COVID-19 antibodies and outcomes among outpatient maintenance hemodialysis patientsю Kidney 360. 2021; 2 (2): 263–9. DOI: https://doi.org/10.34067/KID.0006292020
22. Popova A.Yu., Ezhlova E.B., Mel’nikova A.A., et al. Collective immunity to SARS-COV-2 of Moscow residents during the covid-19 epidemic period. Infektsionnye bolezni [Infectious Diseases]. 2020; 18 (4): 7–14. DOI: https://doi.org/10.20953/1729-9225-2020-4-7-14 (in Russian)
23. Popova A.Yu., Ezhlova E.B., Mel’nikova A.A., et al. The structure of seroprevalence to the SARS-COV-2 virus among residents of the Moscow Region during the period of epidemic incidence of COVID-19. Infektsionnye bolezni [Infectious Diseases]. 2020; 18 (4): 15–23. DOI: https://doi. org/10.20953/1729-9225-2020-4-15-23 (in Russian)
24. Clarke C., Prendecki M., Dhutia A., et al. High prevalence of asymptomatic COVID-19 infection in hemodialysis patients detected using serologic screening. J Am Soc Nephrol. 2020; 31 (9): 1969–75. DOI: https:// doi.org/10.1681/ASN.2020060827
25. Wang R., Liao C., He H., et al. COVID-19 in hemodialysis patients: a report of 5 cases. Am J Kidney Dis. 2020; 76 (1): 141–6. DOI: https://doi. org/10.1053/j.ajkd.2020.03.009
26. Ugur M., Ebru H.A.S., Ozlem K.A., et al. Incidence and immunologic analysis of coronavirus disease (COVID-19) in hemodialysis patients: a single-center experience. Exp Clin Transplant. 2020; 18 (3): 275–83. DOI: https://doi.org/10.6002/ect.2020.0194
27. Ma Y., Diao B., Lv X., et al. 2019 novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan China. medRxiv. URL: https://doi.org/10.1101/2020.02.24.20027201 (date of access June 17, 2020)
28. Goicoechea M., Luis Camara A.S., Macías N., et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. 2020; 98 (1): 27–34. DOI: https://doi.org/10.1016/j.kint.2020.04.031
29. Frolova N.F., Kim I.G., Ushakova A.I., Usatyuk S.S., Artyukhina L.Yu., Iskhakov R.T., et al. COVID-19 in hemodialysis patients. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2021; 10 (1): 14–23. DOI: https://doi. org/10.33029/2305-3496-2021-10-1-14-23 (in Russian)
30. Bai Y., Yao L., Wei T., et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020; 323 (14): 1406–7. DOI: https://doi. org/10.1001/jama.2020.2565
31. Li R., Pei S., Chen B., et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020; 368 (6490): 489–93. DOI: https://doi.org/10.1126/science. abb3221
32. Tang H., Tian J.B., Dong J.W., et al. Serologic detection of SARSCoV-2 infections in hemodialysis centers: a multicenter retrospective study in Wuhan, China. Am J Kidney Dis. 2020; 76 (4): 490–9. DOI: https://doi. org/10.1053/j.ajkd.2020.06.008
33. McMichael T.M., Currie D.W., Clark S., et al. Epidemiology of COVID-19 in a long-term care facility in King County, Washington. N Engl J Med. 2020; 382 (21): 2005–11. DOI: https://doi.org/10.1056/ NEJMoa2005412
34. Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395 (10 229): 1054–62. DOI: https://doi. org/10.1016/S0140-6736(20)30566-3
35. Mehra M.R., Desai S.S., Kuy S., et al. Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med. 2020; 382 (25): e102. DOI: https://doi.org/10.1056/NEJMoa2007621
36. Cummings M.J., Baldwin M.R., Abrams D., et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020; 395 (10 239): 1763–70. DOI: https://doi.org/10.1016/S0140-6736(20)31189-2
37. Sun B., Feng Y., Mo X., et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect. 2020; 9 (1): 940–8. DOI: https://doi.org/10.1080/22221751.2020.1762515
38. Ma Y., Diao B., Lv X., et al. Epidemiological, clinical, and immunological features of a cluster of COVID-19-contracted hemodialysis patients. Kidney Int Rep. 2020; 5 (8): 1333–41. DOI: https://doi.org/10.1016/j. ekir.2020.06.003
39. Betjes M.G. Immune cell dysfunction and inflammation in endstage renal disease. Nat Rev Nephrol. 2013; 9 (5): 255–65. DOI: https:// doi.org/10.1038/nrneph.2013.44
40. Kombarova S.Yu., Aleshkin A.V., Novikova L.I., et al. Dynamics of antibodies to various antigens of the coronavirus SARS-CoV-2 in patients with confirmed COVID-19 infection. COVID-19-PREPRINTS.MICROBE.RU.2020. DOI: htpps://doi.org/10.21055/preprints-3111756 (in Russian)
41. Bundschuh C., Egger M., Wiesinger K., et al. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma. Clin Chim Acta. 2020; 509: 79–82. DOI: htpps://doi.org/10.1016/j.cca.2020.05.047
42. Mahajan A., Manchikanti L. Value and validity of coronavirus antibody testing. Pain Physician. 2020; 23 (4S): 381–90.